Bayforest Capital Ltd acquired a new stake in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 14,140 shares of the company's stock, valued at approximately $429,000.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. SVB Wealth LLC acquired a new position in Bath & Body Works in the first quarter worth about $35,000. Golden State Wealth Management LLC boosted its holdings in Bath & Body Works by 94.7% during the first quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock valued at $40,000 after purchasing an additional 642 shares in the last quarter. UMB Bank n.a. grew its stake in shares of Bath & Body Works by 65.9% in the 1st quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock valued at $46,000 after purchasing an additional 596 shares during the period. GKV Capital Management Co. Inc. acquired a new position in shares of Bath & Body Works in the 1st quarter worth approximately $69,000. Finally, Brooklyn Investment Group lifted its position in shares of Bath & Body Works by 394.9% during the 1st quarter. Brooklyn Investment Group now owns 2,697 shares of the company's stock worth $82,000 after buying an additional 2,152 shares during the period. 95.14% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Several brokerages recently commented on BBWI. Wells Fargo & Company boosted their price target on Bath & Body Works from $40.00 to $44.00 and gave the company an "overweight" rating in a research note on Wednesday, May 14th. Citigroup reduced their target price on shares of Bath & Body Works from $42.00 to $40.00 and set a "buy" rating on the stock in a research note on Tuesday, August 19th. Piper Sandler set a $39.00 target price on shares of Bath & Body Works and gave the stock an "overweight" rating in a research report on Thursday, May 15th. Barclays boosted their price target on shares of Bath & Body Works from $30.00 to $32.00 and gave the company an "equal weight" rating in a research report on Friday, August 29th. Finally, The Goldman Sachs Group decreased their price objective on shares of Bath & Body Works from $44.00 to $43.00 and set a "buy" rating on the stock in a research note on Friday, May 30th. Twelve equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $41.62.
Check Out Our Latest Analysis on BBWI
Bath & Body Works Trading Down 0.8%
Shares of BBWI stock opened at $28.24 on Wednesday. Bath & Body Works, Inc. has a 1 year low of $24.94 and a 1 year high of $41.87. The firm's 50 day moving average is $30.63 and its 200-day moving average is $30.36. The firm has a market capitalization of $5.82 billion, a price-to-earnings ratio of 8.38, a PEG ratio of 0.98 and a beta of 1.49.
Bath & Body Works (NYSE:BBWI - Get Free Report) last released its earnings results on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, hitting analysts' consensus estimates of $0.37. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The company had revenue of $1.55 billion during the quarter, compared to the consensus estimate of $1.55 billion. During the same quarter in the previous year, the company posted $0.37 earnings per share. The firm's quarterly revenue was down .8% on a year-over-year basis. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, equities research analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.
Bath & Body Works Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, September 5th. Investors of record on Friday, August 22nd were paid a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date of this dividend was Friday, August 22nd. Bath & Body Works's dividend payout ratio is presently 23.74%.
About Bath & Body Works
(
Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
